Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02073994
Title Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Institut de Recherches Internationales Servier
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Scottsdale Arizona 85258 United States Details
Los Angeles California 90095 United States Details
Aurora Colorado 80045 United States Details
Miami Florida 33136 United States Details
Baltimore Maryland 21218 United States Details
Boston Massachusetts 02215 United States Details
New York New York 10065 United States Details
Nashville Tennessee 37203 United States Details
Dallas Texas 75390 United States Details
Houston Texas 77030 United States Details
San Antonio Texas 78229 United States Details
Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field